General Fusion Group Ltd. filed a Form 6-K on October 30, 2026, disclosing that founder and Chief Science Officer Dr. Michel Laberge entered into an employment agreement on October 27, 2026, transitioning him to a part-time advisory role effective November 1, 2026.

Key Highlights

  • Role transition: Dr. Michel Laberge, Chief Science Officer and founder, will move to the part-time position of Founder Emeritus effective November 1, 2026.
  • Agreement date: The employment agreement was entered into on October 27, 2026.
  • Term: The Founder Emeritus position runs until December 31, 2027, unless terminated earlier or extended by mutual agreement.
  • Termination notice: Either party may terminate the agreement upon two months' written notice.
  • Compensation: Dr. Laberge will receive a base salary and, for calendar year 2026, will participate in the Company's cash bonus plan.
  • Agreement provisions: The agreement includes invention assignment, confidentiality, non-solicitation, non-competition, and non-disparagement provisions, described as customary.

Dr. Laberge's Transition at General Fusion Group

According to the Form 6-K filed with the U.S. Securities and Exchange Commission, General Fusion Group Ltd. disclosed that Dr. Michel Laberge, who serves as the Company's Chief Science Officer and is its founder, entered into a new employment agreement on October 27, 2026. The filing states that the agreement governs his transition from his current role to the part-time advisory position of Founder Emeritus, with an effective date of November 1, 2026.

The filing indicates that the Founder Emeritus position is set to run through December 31, 2027. The agreement may be terminated earlier in accordance with its terms, including upon two months' written notice by either party, or it may be extended upon the agreement of both parties. As compensation for his service in the new capacity, the filing states Dr. Laberge will be entitled to receive a base salary and, for calendar year 2026, to participate in the Company's cash bonus plan.

The employment agreement, according to the filing, also includes what it describes as "customary invention assignment, confidentiality, non-solicitation, non-competition and non-disparagement provisions." The 6-K was signed on October 30, 2026, by Robert Crystal, Senior Vice President, Finance, on behalf of General Fusion Group Ltd. The filing does not specify the ticker symbol or exchange listing on the cover of this Form 6-K, and the Company files annual reports under Form 20-F.

What Was Disclosed

General Fusion Group Ltd. disclosed via a Form 6-K the terms of an employment agreement with founder Dr. Michel Laberge, transitioning him to a part-time Founder Emeritus role from November 1, 2026, through December 31, 2027, with specified compensation and standard restrictive covenants.